Placebo group | Lidocaine group | Paracetamol group | p | |
EVS 0 | 9 (15%) | 47 (78.3%) | 38 (63.3%) | <0.01 |
EVS 1 | 14 (23.3%) | 7 (11.7%) | 11 (18.3%) | <0.01 |
EVS 2 | 16 (26.7%) | 5 (8.3%) | 6 (10%) | <0.01 |
EVS 3 | 21 (35%) | 1 (1.7%) | 5 (8.3%) | <0.01 |
EVS > 0 (1 + 2 + 3) | 51 (85%) | 13 (21.7%) | 22 (36.6%) | <0.01 |